Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
Sign Up
Log in
O

Optus Pharmaceutical Co Ltd
KOSDAQ:131030

Watchlist Manager
Optus Pharmaceutical Co Ltd
KOSDAQ:131030
Watchlist
Price: 10 000 KRW 10.25%
Market Cap: ₩176.5B
Write Note Create Alert Ask AI

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
What is Dividend Safety Rate?
Previous Payment
-
Today
Next Payment
-
Today
Apr 13, 2026
Previous Payment
-
Next Payment
-
Ex-Dividend Date
-

Dividend Yield
Optus Pharmaceutical Co Ltd

Period
3Y
5Y
10Y
15Y
30Y
Yield Statistics, Past 5 Years
Min
Max
Current Yield
Min Yield
Max Yield
Average Yield
Median Yield

Dividend Per Share
Optus Pharmaceutical Co Ltd

Over the past 5 years, dividends per share for Optus Pharmaceutical Co Ltd have decreased by 0%.
What is dividend per share?
Dividend Streak
Growth 3Y
Growth 5Y
Growth 10Y
3Y
5Y
10Y
15Y
30Y
Ex-Dividend Date Amount Period Declaration Date Record Date Payment Date
Load More

Payout Ratio
Optus Pharmaceutical Co Ltd

Period
3Y
5Y
10Y
15Y
30Y
Payout Statistics, Past 5 Years
Min
Max
Current Payout
Min Payout Unlock
Max Payout Unlock
Average Payout Unlock
Median Payout Unlock

Peers Comparison
Dividends

Company Safety Rate Dividend Yield Dividend Per Share Growth 5Y Growth 10Y Payout Ratio

Shareholder Yield

Current shareholder yield for Optus Pharmaceutical Co Ltd is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
= Dividend Yield
+ Buyback Yield
+ Debt Paydown Yield
Shareholder Yield
LOCKED
Unlock
Dividend Yield
Lowest
Average
Highest
Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Peers Comparison
Shareholder Yield

Company Total Yield Dividend Yield Buyback Yield Debt Paydown Yield

Buybacks

Buyback Yield
available only for registered users

Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.

This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.

Unlock Buyback Yield

Peers Comparison
Buybacks

Company Buyback Yield Average Yield (3Y) Average Yield (5Y) Average Yield (10Y)

Debt Paydown

Debt Paydown Yield
available only for registered users

Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.

This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.

Unlock Debt Paydown Yield

Peers Comparison
Debt Paydown

Company Debt Paydown Yield Average Yield (3Y) Average Yield (5Y) Average Yield (10Y)

Price Appreciation

Price
Optus Pharmaceutical Co Ltd

1Y 3Y 5Y 10Y 15Y 20Y
Annual Price Range
10 000
52w Low
6 040
52w High
19 260
Price Metrics
Average Annual Return -5.6%
Standard Deviation of Annual Returns 14.6%
Max Drawdown -54%
Shares Statistics
Market Capitalization 176.5B KRW
Shares Outstanding 17 650 000
Percentage of Shares Shorted
N/A

Return Decomposition
Main factors of price return

Stock Splits

No Stock Splits Found

We don't have any information about Optus Pharmaceutical Co Ltd's stock splits.

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 329,900+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett